The FDA accepted a new drug application for SYD-101 to slow the progression of pediatric myopia and assigned a Prescription ...
International Delight coffee creamer sold in Mississippi now under FDA recall. Did you buy them? Are they in your home? What you need to know.
The FDA has set a PDUFA target action date of October 23, 2025, for the low-dose atropine formulation.
Nebokitug is the drug name recently assigned to CM-101 by the International Nonproprietary Names, or INN, program of the World Health Organization. The PSC pivotal trial design is focused on a set ...
FDA assigns a PDUFA target action date of October 23, 2025 If approved, SYD-101 would be the first and only pharmaceutical treatment option proven to slow the progression of pediatric myopia ...
The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for SYD-101 (atropine sulfate) to slow the progression of ...
If approved, SYD-101 would be the first and only pharmaceutical option for the treatment of progression of pediatric myopia in the United States. “The FDA acceptance of our NDA filing for SYD ...